Growth Metrics

Cryo Cell International (CCEL) Cash from Financing Activities (2016 - 2026)

Cryo Cell International's Cash from Financing Activities history spans 16 years, with the latest figure at -$740290.0 for Q1 2026.

  • Quarterly results put Cash from Financing Activities at -$740290.0 for Q1 2026, up 26.3% from a year ago — trailing twelve months through Feb 2026 was -$4.5 million (down 77.64% YoY), and the annual figure for FY2025 was -$4.7 million, down 384.64%.
  • Cash from Financing Activities for Q1 2026 was -$740290.0 at Cryo Cell International, up from -$937340.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $8.7 million in Q3 2022 to a low of -$5.6 million in Q4 2022.
  • The 5-year median for Cash from Financing Activities is -$772847.0 (2023), against an average of -$493508.2.
  • Peak annual rise in Cash from Financing Activities hit 1217.08% in 2022, while the deepest fall reached 1476.04% in 2022.
  • Year by year, Cash from Financing Activities stood at -$5.6 million in 2022, then skyrocketed by 72.32% to -$1.5 million in 2023, then skyrocketed by 56.0% to -$677821.0 in 2024, then crashed by 38.29% to -$937340.0 in 2025, then grew by 21.02% to -$740290.0 in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$740290.0, -$937340.0, and -$3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.